Literature DB >> 23217326

Deleterious- and disease-allele prevalence in healthy individuals: insights from current predictions, mutation databases, and population-scale resequencing.

Yali Xue1, Yuan Chen, Qasim Ayub, Ni Huang, Edward V Ball, Matthew Mort, Andrew D Phillips, Katy Shaw, Peter D Stenson, David N Cooper, Chris Tyler-Smith.   

Abstract

We have assessed the numbers of potentially deleterious variants in the genomes of apparently healthy humans by using (1) low-coverage whole-genome sequence data from 179 individuals in the 1000 Genomes Pilot Project and (2) current predictions and databases of deleterious variants. Each individual carried 281-515 missense substitutions, 40-85 of which were homozygous, predicted to be highly damaging. They also carried 40-110 variants classified by the Human Gene Mutation Database (HGMD) as disease-causing mutations (DMs), 3-24 variants in the homozygous state, and many polymorphisms putatively associated with disease. Whereas many of these DMs are likely to represent disease-allele-annotation errors, between 0 and 8 DMs (0-1 homozygous) per individual are predicted to be highly damaging, and some of them provide information of medical relevance. These analyses emphasize the need for improved annotation of disease alleles both in mutation databases and in the primary literature; some HGMD mutation data have been recategorized on the basis of the present findings, an iterative process that is both necessary and ongoing. Our estimates of deleterious-allele numbers are likely to be subject to both overcounting and undercounting. However, our current best mean estimates of ~400 damaging variants and ~2 bona fide disease mutations per individual are likely to increase rather than decrease as sequencing studies ascertain rare variants more effectively and as additional disease alleles are discovered.
Copyright © 2012 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23217326      PMCID: PMC3516590          DOI: 10.1016/j.ajhg.2012.10.015

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  43 in total

1.  Identification of novel USH2A mutations: implications for the structure of USH2A protein.

Authors:  B Dreyer; L Tranebjaerg; T Rosenberg; M D Weston; W J Kimberling; O Nilssen
Journal:  Eur J Hum Genet       Date:  2000-07       Impact factor: 4.246

Review 2.  Defining the phenotypes of sickle cell disease.

Authors:  Samir K Ballas
Journal:  Hemoglobin       Date:  2011-09-20       Impact factor: 0.849

3.  Our load of mutations.

Authors:  H J MULLER
Journal:  Am J Hum Genet       Date:  1950-06       Impact factor: 11.025

4.  The STOX1 genotype associated with pre-eclampsia leads to a reduction of trophoblast invasion by alpha-T-catenin upregulation.

Authors:  Marie van Dijk; Jan van Bezu; Daan van Abel; Caroline Dunk; Marinus A Blankenstein; Cees B M Oudejans; Stephen J Lye
Journal:  Hum Mol Genet       Date:  2010-04-16       Impact factor: 6.150

5.  A population-based study of autosomal-recessive disease-causing mutations in a founder population.

Authors:  Jessica X Chong; Rebecca Ouwenga; Rebecca L Anderson; Darrel J Waggoner; Carole Ober
Journal:  Am J Hum Genet       Date:  2012-09-13       Impact factor: 11.025

Review 6.  Raising the estimate of functional human sequences.

Authors:  Michael Pheasant; John S Mattick
Journal:  Genome Res       Date:  2007-08-09       Impact factor: 9.043

7.  Taxonomizing, sizing, and overcoming the incidentalome.

Authors:  Isaac S Kohane; Michael Hsing; Sek Won Kong
Journal:  Genet Med       Date:  2012-02-09       Impact factor: 8.822

8.  A systematic survey of loss-of-function variants in human protein-coding genes.

Authors:  Daniel G MacArthur; Suganthi Balasubramanian; Adam Frankish; Ni Huang; James Morris; Klaudia Walter; Luke Jostins; Lukas Habegger; Joseph K Pickrell; Stephen B Montgomery; Cornelis A Albers; Zhengdong D Zhang; Donald F Conrad; Gerton Lunter; Hancheng Zheng; Qasim Ayub; Mark A DePristo; Eric Banks; Min Hu; Robert E Handsaker; Jeffrey A Rosenfeld; Menachem Fromer; Mike Jin; Xinmeng Jasmine Mu; Ekta Khurana; Kai Ye; Mike Kay; Gary Ian Saunders; Marie-Marthe Suner; Toby Hunt; If H A Barnes; Clara Amid; Denise R Carvalho-Silva; Alexandra H Bignell; Catherine Snow; Bryndis Yngvadottir; Suzannah Bumpstead; David N Cooper; Yali Xue; Irene Gallego Romero; Jun Wang; Yingrui Li; Richard A Gibbs; Steven A McCarroll; Emmanouil T Dermitzakis; Jonathan K Pritchard; Jeffrey C Barrett; Jennifer Harrow; Matthew E Hurles; Mark B Gerstein; Chris Tyler-Smith
Journal:  Science       Date:  2012-02-17       Impact factor: 47.728

9.  The Human Gene Mutation Database: 2008 update.

Authors:  Peter D Stenson; Matthew Mort; Edward V Ball; Katy Howells; Andrew D Phillips; Nick St Thomas; David N Cooper
Journal:  Genome Med       Date:  2009-01-22       Impact factor: 11.117

10.  Assessing the evolutionary impact of amino acid mutations in the human genome.

Authors:  Adam R Boyko; Scott H Williamson; Amit R Indap; Jeremiah D Degenhardt; Ryan D Hernandez; Kirk E Lohmueller; Mark D Adams; Steffen Schmidt; John J Sninsky; Shamil R Sunyaev; Thomas J White; Rasmus Nielsen; Andrew G Clark; Carlos D Bustamante
Journal:  PLoS Genet       Date:  2008-05-30       Impact factor: 5.917

View more
  134 in total

1.  Genomics is rapidly advancing precision medicine for immunological disorders.

Authors:  Yu Zhang; Helen C Su; Michael J Lenardo
Journal:  Nat Immunol       Date:  2015-10       Impact factor: 25.606

Review 2.  From the genetic architecture to synaptic plasticity in autism spectrum disorder.

Authors:  Thomas Bourgeron
Journal:  Nat Rev Neurosci       Date:  2015-09       Impact factor: 34.870

Review 3.  Genomics of Immune Diseases and New Therapies.

Authors:  Michael Lenardo; Bernice Lo; Carrie L Lucas
Journal:  Annu Rev Immunol       Date:  2015-12-23       Impact factor: 28.527

4.  De novo loss-of-function mutations in SETD5, encoding a methyltransferase in a 3p25 microdeletion syndrome critical region, cause intellectual disability.

Authors:  Detelina Grozeva; Keren Carss; Olivera Spasic-Boskovic; Michael J Parker; Hayley Archer; Helen V Firth; Soo-Mi Park; Natalie Canham; Susan E Holder; Meredith Wilson; Anna Hackett; Michael Field; James A B Floyd; Matthew Hurles; F Lucy Raymond
Journal:  Am J Hum Genet       Date:  2014-03-27       Impact factor: 11.025

Review 5.  Applications of high-throughput DNA sequencing to benign hematology.

Authors:  Vijay G Sankaran; Patrick G Gallagher
Journal:  Blood       Date:  2013-09-10       Impact factor: 22.113

6.  Reply to Rational drug repositioning by medical genetics.

Authors:  Philippe Sanseau; Pankaj Agarwal; Michael R Barnes; Tomi Pastinen; J Brent Richards; Lon R Cardon; Vincent Mooser
Journal:  Nat Biotechnol       Date:  2013-12       Impact factor: 54.908

7.  Long runs of homozygosity are enriched for deleterious variation.

Authors:  Zachary A Szpiech; Jishu Xu; Trevor J Pemberton; Weiping Peng; Sebastian Zöllner; Noah A Rosenberg; Jun Z Li
Journal:  Am J Hum Genet       Date:  2013-06-06       Impact factor: 11.025

8.  Neutral and weakly nonneutral sequence variants may define individuality.

Authors:  Yana Bromberg; Peter C Kahn; Burkhard Rost
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-12       Impact factor: 11.205

9.  Complexity and diversity of F8 genetic variations in the 1000 genomes.

Authors:  J N Li; I G Carrero; J F Dong; F L Yu
Journal:  J Thromb Haemost       Date:  2015-10-20       Impact factor: 5.824

10.  Assessing the phenotypic effects in the general population of rare variants in genes for a dominant Mendelian form of diabetes.

Authors:  Jason Flannick; Nicola L Beer; Alexander G Bick; Vineeta Agarwala; Janne Molnes; Namrata Gupta; Noël P Burtt; Jose C Florez; James B Meigs; Herman Taylor; Valeriya Lyssenko; Henrik Irgens; Ervin Fox; Frank Burslem; Stefan Johansson; M Julia Brosnan; Jeff K Trimmer; Christopher Newton-Cheh; Tiinamaija Tuomi; Anders Molven; James G Wilson; Christopher J O'Donnell; Sekar Kathiresan; Joel N Hirschhorn; Pål R Njølstad; Tim Rolph; J G Seidman; Stacey Gabriel; David R Cox; Christine E Seidman; Leif Groop; David Altshuler
Journal:  Nat Genet       Date:  2013-10-06       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.